Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation Expense (Tables)

v2.4.0.8
Stock-Based Compensation Expense (Tables)
12 Months Ended
Mar. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of shares outstanding
A summary of stock option activity under our Stock Plans for fiscal 2014, fiscal 2013 and fiscal 2012 are as follows:
 
 
 
Options Outstanding
 
 
 
Number of Shares
 
Weighted Average Exercise Price
Balance at March 31, 2011
 
2,757,524

 
$
5.38

 
Granted
 
117,600

 
12.00

 
Exercised
 
(683,443
)
 
5.38

 
Forfeited
 
(12,056
)
 
6.46

Balance at March 31, 2012
 
2,179,625

 
$
5.74

 
Granted
 
56,532

 
21.52

 
Exercised
 
(1,086,486
)
 
5.31

 
Forfeited
 
(16,891
)
 
7.98

Balance at March 31, 2013
 
1,132,780

 
$
6.98

 
Exercised
 
(566,487
)
 
5.90

 
Forfeited
 
(7,827
)
 
15.73

Balance at March 31, 2014
 
558,466

 
$
7.96

Schedule of nonvested share activity
For fiscal 2014, fiscal 2013 and fiscal 2012 the intrinsic value of stock option exercises was $10,285, $18,387, and $8,860, respectively. For the year ended March 31, 2014, the Company had a tax loss in the United States and therefore did not recognize an excess tax deduction from options exercised of $1,452. For the years ended March 31, 2013 and 2012, this benefit was $4,131 and $2,181, respectively and was recorded in Additional paid in capital.

 
 
 
Unvested Options
 
 
 
Number of Shares
 
Weighted Average Grant Date Fair Value
Balance at March 31, 2011
 
2,757,524

 
$
2.97

 
Granted
 
117,600

 
5.99

 
Vested
 
(2,757,524
)
 
2.97

Balance at March 31, 2012
 
117,600

 
$
5.99

 
Granted
 
56,532

 
12.26

 
Vested
 
(23,520
)
 
5.99

 
Forfeited
 
(4,386
)
 
8.32

Balance at March 31, 2013
 
146,226

 
$
8.34

 
Vested
 
(33,001
)
 
6.92

 
Forfeited
 
(7,827
)
 
8.32

Balance at March 31, 2014
 
105,398

 
$
8.33

Schedule of shares oustanding, vested and exercisable
The following table summarizes information about stock options outstanding as of March 31, 2014:

 
 
Options Outstanding
 
Options Vested and Exercisable
Exercise Price
 
Number Outstanding
 
Weighted Average Contractual Life (Years)
 
Weighted Average Exercise Price
 
Aggregate Intrinsic Value at March 31, 2014
 
Number Vested and Exercisable
 
Weighted Average Contractual Life (Years)
 
Weighted Average Exercise Price
 
Aggregate Intrinsic Value at March 31, 2014
$5.20
 
393,327

 
6.55
 
$
5.20

 
$
7,072,019

 
393,327

 
6.55
 
$
5.20

 
$
7,072,019

$9.82
 
26,821

 
6.91
 
9.82

 
358,329

 
26,821

 
6.91
 
9.82

 
358,329

$12.00
 
88,104

 
7.12
 
12.00

 
985,003

 
24,054

 
7.12
 
12.00

 
268,924

$21.52
 
50,214

 
8.34
 
21.52

 
83,355

 
8,866

 
8.34
 
21.52

 
14,718

$5.20-$21.52
 
558,466

 
6.81
 
$
7.96

 
$
8,498,706

 
453,068

 
6.64
 
$
6.15

 
$
7,713,990

Schedule of valuation assumptions used
No options were granted in fiscal 2014.
 
 
 
Year Ended March 31, 2013
 
Year Ended March 31, 2012
 
Expected life
 
6.50

 
6.66

 
Expected volatility
 
59.9
%
 
45.0
%
 
Risk free interest rate
 
0.98
%
 
3.25
%
 
Dividend expense yield
 

 

Schedule restricted stock activity
 
Restricted Stock Awards
 
Number of Shares
 
Weighted Average Grant Price
Balance at March 31, 2011
 

 
$

 
Granted
 
16,136

 
12.42

 
Released
 

 

 
Forfeited
 

 

Balance of unvested awards at March 31, 2012
 
16,136

 
$
12.42

 
Granted
 
13,012

 
21.52

 
Released
 
(8,068
)
 
12.42

 
Forfeited
 

 

Balance of unvested awards at March 31, 2013
 
21,080

 
$
18.09

 
Granted
 
17,416

 
20.09

 
Released
 
(20,980
)
 
18.09

 
Forfeited
 

 

Balance of unvested awards at March 31, 2014
 
17,516

 
$
20.09

 
Restricted Stock Units
 
Number of Shares
 
Weighted Average Grant Fair Value
Balance at March 31, 2012
 

 
$

 
Granted
 
71,923

 
21.52

 
Released
 

 

 
Forfeited
 
(814
)
 
21.52

Balance of unvested units at March 31, 2013
 
71,109

 
$
21.52

 
Granted
 
117,904

 
20.14

 
Released
 
(18,786
)
 
21.52

 
Forfeited
 
(5,902
)
 
21.52

Balance of unvested units at March 31, 2014
 
164,325

 
$
20.53